BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9561377)

  • 1. Positive blood cultures for coagulase-negative staphylococci in neonates: does highly selective vancomycin usage affect outcome?
    Matrai-Kovalskis Y; Greenberg D; Shinwell ES; Fraser D; Dagan R
    Infection; 1998; 26(2):85-92. PubMed ID: 9561377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
    Mashaly GE; El-Mahdy RH
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study.
    Lawrence SL; Roth V; Slinger R; Toye B; Gaboury I; Lemyre B
    BMC Pediatr; 2005 Dec; 5():49. PubMed ID: 16375769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices.
    Rubin LG; Sánchez PJ; Siegel J; Levine G; Saiman L; Jarvis WR;
    Pediatrics; 2002 Oct; 110(4):e42. PubMed ID: 12359815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China.
    Cui J; Liang Z; Mo Z; Zhang J
    Antimicrob Resist Infect Control; 2019; 8():65. PubMed ID: 31044070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of invasive staphylococcal disease in neonates.
    Healy CM; Palazzi DL; Edwards MS; Campbell JR; Baker CJ
    Pediatrics; 2004 Oct; 114(4):953-61. PubMed ID: 15466090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seven-year survey of management of coagulase-negative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy.
    Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
    Neonatology; 2011; 100(2):180-5. PubMed ID: 21455008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulase-negative staphylococcal bloodstream infections: Does vancomycin remain appropriate empiric therapy?
    Valencia-Rey P; Weinberg J; Miller NS; Barlam TF
    J Infect; 2015 Jul; 71(1):53-60. PubMed ID: 25725152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.
    Ericson JE; Thaden J; Cross HR; Clark RH; Fowler VG; Benjamin DK; Cohen-Wolkowiez M; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Apr; 34(4):371-5. PubMed ID: 25760564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit.
    Blanchard AC; Fortin E; Laferrière C; Goyer I; Moussa A; Autmizguine J; Quach C
    J Antimicrob Chemother; 2017 Jun; 72(6):1812-1817. PubMed ID: 28333257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of QuickFISH in addition to antimicrobial stewardship on vancomycin use and resource utilization in cancer patients with coagulase-negative staphylococcal blood cultures.
    Seo SK; Gedrimaite Z; Paskovaty A; Seier K; Morjaria S; Cohen N; Riedel E; Tang YW; Babady NE
    Clin Microbiol Infect; 2018 Dec; 24(12):1339.e7-1339.e12. PubMed ID: 29549061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.
    Linder N; Lubin D; Hernandez A; Amit L; Ashkenazi S
    Br J Clin Pharmacol; 2013 Jul; 76(1):58-64. PubMed ID: 23210694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of PBP-2A by neonatal mecA-positive coagulase-negative staphylococci (CoNS) blood isolates: β-lactams are useful first-line agents for the treatment of neonatal CoNS sepsis, restricting the use of vancomycin.
    Fleer A; Hemels MA; Paauw A; Krediet TG
    J Antimicrob Chemother; 2012 Jul; 67(7):1616-8. PubMed ID: 22438436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
    Heywood A; Bargman JM
    Adv Perit Dial; 2010; 26():34-6. PubMed ID: 21348376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose vancomycin prophylaxis reduces coagulase-negative staphylococcal bacteraemia in very low birthweight infants.
    Cooke RW; Nycyk JA; Okuonghuae H; Shah V; Damjanovic V; Hart CA
    J Hosp Infect; 1997 Dec; 37(4):297-303. PubMed ID: 9457607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response.
    Klingenberg C; Aarag E; Rønnestad A; Sollid JE; Abrahamsen TG; Kjeldsen G; Flaegstad T
    Pediatr Infect Dis J; 2005 Sep; 24(9):817-22. PubMed ID: 16148849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Validity of Positive Coagulase-Negative Staphylococcus Cultures for the Diagnosis of Sepsis in the Neonatal Unit.
    Benenson S; Cohen MJ; Greenglick N; Schwartz C; Eventov-Friedman S; Ergaz Z
    Am J Perinatol; 2024 Jul; 41(9):1245-1250. PubMed ID: 35381607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset sepsis: comparison between coagulase-negative staphylococci and other bacteria in the neonatal intensive care unit.
    Berlak N; Shany E; Ben-Shimol S; Chertok IA; Goldinger G; Greenberg D; Melamed R
    Infect Dis (Lond); 2018 Oct; 50(10):764-770. PubMed ID: 29969049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
    Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.